Enter your ZIP code:

Please enter a 5 digit zipcode
No results...

Entering your zip code helps us to provide information and results that are more relevant to you.

Your privacy is important to us. By continuing, you agree to our Privacy Policy.





ComprehensiveImagingStudyProstate

Cancer
Edward Uchio
CoMprehensive imAging study of the Prostate (MAP)
Prostate

Study Description

This is an observational, prospective, multi-center, single-arm imaging

study. Participants who are scheduled for a prostate biopsy will undergo

comprehensive imaging with the GE LOGIQ E10s US, CT and MR. The Imaging

Acquisition Guidelines (IAGs) detail imaging parameters and participant position

requirements.

Eligibility

General Inclusion

  1. Participant is ≥40 years of age.
  2. Participant has signed the Institutional Review Board (IRB) approved study Informed Consent

Form (ICF) prior to any study related tests/procedures and is willing to comply with study

procedures and required follow-up assessments.

  1. Participant is scheduled for a prostate biopsy

General Exclusion

  1. Participant has prior prostate cancer treatment (e.g., radiation, ablative therapies)
A female nurse attentively holds a tablet, ready to assist with patient care and medical information.

Interested in Participating in this Trial?

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.